Hartwig Andreas Steckel

Title: Hartwig Andreas Steckel: Innovator in Powdered Inhalants

Introduction

Hartwig Andreas Steckel is a notable inventor based in Schoenkirchen, Germany. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of powdered inhalants. With a total of two patents to his name, Steckel's work focuses on improving the efficacy and delivery of inhalable medications.

Latest Patents

Steckel's latest patents include innovative processes for preparing modified lactose mixtures. The first patent, titled "Powdered inhalants based on modified lactose mixtures as excipient," relates to a new method for creating these lactose mixtures. This invention also encompasses compositions of medicaments for powder inhalation that consist of one or more micronised active substances combined with the modified lactose. The second patent, "Surface modification of lactose excipient for use in powders for inhalation," details a process for the surface-energy passivation of lactose. This optimized carrier material is intended for use in the production of inhalable powders, enhancing their performance.

Career Highlights

Throughout his career, Hartwig Andreas Steckel has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Boehringer Ingelheim International GmbH and Boehringer Ingelheim Pharma GmbH & Co. KG. His experience in these organizations has contributed to his expertise in the development of inhalable drug formulations.

Collaborations

Steckel has collaborated with several professionals in his field, including Bernd Wilhelm Mueller and Inga-Lis Timmermann. These collaborations have likely enriched his research and development efforts, leading to innovative solutions in inhalation therapy.

Conclusion

Hartwig Andreas Steckel's contributions to the field of powdered inhalants demonstrate his commitment to advancing pharmaceutical technology. His patents reflect a deep understanding of excipients and their role in medication delivery. Through his work, he continues to impact the development of effective inhalable therapies.